`571-272-7822
`
`
`
`
`
`
`
`
`
`
`
`
` Paper No. 16
` Entered: November 1, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ARGENTUM PHARMACEUTICALS LLC,
`
`Petitioner,
`
`v.
`
`ALCON RESEARCH, LTD.,
`
`Patent Owner.
`_______________
`
`Case IPR2017-01053
`Patent 8,268,299 B2
`_______________
`
`
`
`Before RICHARD E. SCHAFER, GRACE KARAFFA OBERMANN,
`and SUSAN L. C. MITCHELL, Administrative Patent Judges.
`
`
`
`OBERMANN, Administrative Patent Judge.
`
`
`
`DECISION
`Granting Patent Owner’s Motion for
`Pro Hac Vice Admission of Christopher J. Mandernach
`37 C.F.R. § 42.10(c)
`
`
`
`IPR2017-01053
`Patent 8,268,299 B2
`
`
`On October 24, 2017, Patent Owner filed a motion for pro hac vice
`admission of Christoperh J. Mandernach (Paper 12) supported by a
`declaration of Mr. Mandernach (Exhibit 2003). Petitioner did not file an
`opposition. See Paper 5, 2 (citing Unified Patents, Inc. v. Parallel Iron,
`LLC, Case IPR2013-00639 (PTAB Oct. 15, 2013) (Paper 7) (setting a one
`week time period for filing an opposition to a motion for pro hac vice
`admission)). Based on our review of Patent Owner’s motion and
`Mr. Mandernach’s declaration, we determine that Patent Owner establishes
`“good cause” for the admission.
`
`It is:
`ORDERED that Patent Owner’s motion for pro hac vice admission of
`Mr. Mandernach is granted; Mr. Mandernach is authorized to represent
`Patent Owner only as back-up counsel in the instant proceedings;
`FURTHER ORDERED that Patent Owner is to continue to have a
`registered practitioner represent it as lead counsel in the instant proceedings;
`FURTHER ORDERED that Mr. Mandernach shall comply with the
`Office Patent Trial Practice Guide and the Board’s Rules of Practice for
`Trials, as set forth in Part 42 of Title 37, Code of Federal Regulations; and
`FURTHER ORDERED that Mr. Mandernach shall be subject to the
`Office’s disciplinary jurisdiction under 37 C.F.R. § 11.19(a), and the
`USPTO Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et.
`seq.
`
`
`
`
`2
`
`
`
`IPR2017-01053
`Patent 8,268,299 B2
`
`PETITIONER:
`
`Michael R. Houston, Ph.D.
`Joseph P. Meara, Ph.D.
`James P. McParland, Ph.D.
`FOLEY & LARDNER LLP
`mhouston@foley.com
`jmeara-pgp@foley.com
`jmcparland@foley.com
`
`Tyler C. Liu
`ARGENTUM PHARMACEUTICALS LLC
`tliu@agpharm.com
`
`
`
`PATENT OWNER:
`
`David Krinsky
`Christopher Suarez
`WILLIAMS & CONNOLLY LLP
`dkrinsky@wc.com
`csuarez@wc.com
`
`
`3
`
`